(127 days)
The Equivital™ Vital Signs Physiological Monitor is an ambulatory multiparameter vital signs telemetry device intended for monitoring of adults (16 - 65years) in hospital in the mital in the mater vital care facilities, the home, workplace for monitoning of addits (11) facilities, the home, workplace and alternate care settings.
The device consists of a chest belt harness and a body worn electronics module (SEM) supported by the chest belt.
The device collects and transmits ECG data and rate, respiration data and rate, skin temperature, body orientation and motion temperature, body orientation and motion.
The monitor is indicated for use as a general patient monitor, to provide physiological information as part of an occupational welfare monitor, to provide physiology research and performance measuroment purpos research and performance measurement purposes.
The Equivital™ Vital Signs Physiological Monitor comprises two components:
i) A chest belt containing skin electrodes and an expansion sensor
ii) A battery powered electronics module which connects directly to the chest belt and which acts to record, digitise and transmit the physiological information wirelessly to a receiving display device.
The device offers continuous monitoring of two views of the user's heart electrical activity (ECG) and respiratory breathing frequency inferred from thoracic cavity movement and uses this data to derive a Heart Rate and a Breathing Effort Rate.
The sensor also provides the following information:
- ECG and Respiration physiological waveforms .
- An indication of the user's activity level derived from a movement detection sensor .
- Body orientation and indications for change in orientation .
- Skin surface temperature .
- Alternate secondary measurement of heart rate based on the detection of the user's R . wave using a separate hardware processing function
- . Indications and alerts if physiology exceeds predefined boundaries
- Alternate secondary skin temperature measurement using infrared thermometer .
The device offers two variants for the wireless interface: a low power radio interface and a general purpose interface using Bluetooth™ technology.
The device offers two battery power options for the user, rechargeable or primary disposable cells.
The wireless data provided by the sensor may be viewed using a standalone PC based viewing application, or integrated into third party monitoring applications.
This document describes the Equivital™ Vital Signs Physiological Monitor EQ02, but it does not contain a detailed study demonstrating its performance against specific acceptance criteria for each measured parameter.
Instead, the submission focuses on demonstrating substantial equivalence to a previously cleared predicate device (Equivital EQ01) and compliance with relevant safety and electromagnetic compatibility standards.
Here's a breakdown of the information requested, based on the provided text:
1. Table of Acceptance Criteria and Reported Device Performance
This table cannot be fully populated as specific performance acceptance criteria (e.g., accuracy ranges for heart rate, respiration rate, temperature) and the numerical results of studies proving these criteria were met are not explicitly provided in the given text.
The document states that "Performance measurement and review to the applicable sections of the following standards has been undertaken and successfully demonstrated as recommended by available guidance from the agency." This implies that performance was verified against the requirements of these standards, but the specific numerical acceptance criteria and the device's measured performance against them are not detailed.
| Parameter | Acceptance Criteria (from Standards, e.g., ANSI/AAMI EC13) | Reported Device Performance (numerical results of testing) |
|---|---|---|
| ECG Heart Rate | Not explicitly stated in document | "successfully demonstrated as recommended by available guidance from the agency" against ANSI/AAMI EC13 |
| Respiration Rate | Not explicitly stated in document | "successfully demonstrated as recommended by available guidance from the agency" |
| Skin Temperature | Not explicitly stated in document | "successfully demonstrated as recommended by available guidance from the agency" against ASTM E1965 98 (2009) |
| Activity Level | Not explicitly stated in document | "successfully demonstrated as recommended by available guidance from the agency" |
| Body Orientation | Not explicitly stated in document | "successfully demonstrated as recommended by available guidance from the agency" |
| Physiological Alerts | Not explicitly stated in document | "successfully demonstrated as recommended by available guidance from the agency" against ANSI/AAMI EC13 |
| Safety | EN60601-1 | "successfully demonstrated" |
| EMC | IEC60601-1-2 | "successfully demonstrated" |
| Biocompatibility | ISO 10993-1 | "successfully demonstrated" |
| Software | EN60601-1-4 | "meets the requirements" |
| Environmental | IP67 | "successfully demonstrated" |
2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)
This information is not provided in the document. The submission references "Performance measurement and review" and "testing undertaken" but does not detail the methodology, sample sizes, or data provenance for these tests.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)
This information is not provided in the document. The document describes a medical device for physiological monitoring, not a diagnostic imaging or AI device requiring expert ground truth for image interpretation. The "ground truth" for vital signs monitoring would typically come from comparison to a highly accurate reference device or direct physiological measurements, not expert consensus in the same way an AI diagnostic model would.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set
This information is not provided in the document. Adjudication methods like 2+1 or 3+1 are typically used in studies where human readers are making subjective interpretations (e.g., radiology studies). For a vital signs monitor, the comparison would be against a reference standard or objective measurements, not subjective human interpretations requiring adjudication.
5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
No, a multi-reader multi-case (MRMC) comparative effectiveness study was not conducted or reported for this device. This is a vital signs monitor, not an AI-powered diagnostic tool, so such a study would not be applicable in this context. The device's function is to collect and transmit physiological data, not to assist human readers in interpreting complex cases.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
The device itself is a "standalone" physiological monitor in the sense that it collects and processes data to derive heart rate, respiration rate, and other parameters directly from sensor inputs. The performance claimed (e.g., accurate heart rate calculation) is inherent to its algorithms. However, the document does not report a specific "standalone" performance study in the context of an AI algorithm being evaluated against human performance or ground truth. It refers to performance measurement against standards, which implies the device's accuracy in measuring various parameters.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)
The document does not explicitly state the specific "ground truth" methods used for the performance evaluations. However, based on the nature of medical device testing for vital signs monitors, the ground truth would typically be established by:
- Comparison to a gold-standard reference device: For parameters like heart rate, respiration rate, and temperature, laboratories use highly accurate and calibrated reference instruments to provide the "true" value against which the device under test is compared.
- Direct physiological measurements: In some cases, direct measurements (e.g., manual respiration counts, core body temperature probes) might be used as a reference.
It would not typically involve expert consensus, pathology, or outcomes data for the primary performance assessment of vital sign accuracy.
8. The sample size for the training set
This information is not applicable and not provided. The Equivital™ Vital Signs Physiological Monitor EQ02 is described as a telemetry device and monitor, not an AI/machine learning model that undergoes "training" in the conventional sense with a distinct training set. Its functionality is based on established signal processing and sensor technologies, not adaptive learning from a large dataset.
9. How the ground truth for the training set was established
This information is not applicable and not provided. As stated above, the device does not use a "training set" in the context of machine learning. Its algorithms are likely based on fixed rules and signal processing techniques designed and validated through engineering principles.
{0}------------------------------------------------
KII3054 hidalgo
FEB 1 7 2012
510(k) Summary Equivital Vital Signs Physiological Monitor EQ02
| Submitter: | Hidalgo Ltd |
|---|---|
| Unit FBuckingway Business ParkAnderson RoadSwaveseyCambridgeCB24 4UQUnited Kingdom | |
| Contact: | Dr Ekta Sood - Clinical DirectorTel: +441954233430 |
| Date: | 2011-10-10 |
Name of Device:
| Device Trade Name: | Equivital™ Vital Signs Physiological Monitor EQ0 |
|---|---|
| Device Common Name: | Ambulatory Patient Monitor |
Device Classification and Product Code:
-
Class Ilb EU:
Medical Device Directive: 93/42/EEC as amended by 2007/47/EC -
USA: Class II
- Panel: Cardiovascular
Product Code: MHX
Regulation Number: 870.1025
Classification Name: Monitor, Physiological, Patient
(With Arrhythmia Detection Or Alarms)
Image /page/0/Picture/16 description: The image shows the logo for Jaltek. The logo consists of the word "jaltek" in lowercase letters, with a stylized globe above it. The globe appears to have land masses and oceans depicted on its surface.
Hidalgo Ilmited - A Jaltek Group Company
Unit F, Buckingway Business Park, Anderson Road, Swavesey, Cambridge, CB24 4UQ Fax: +44 (0) 1954 233431 Web: www.hidalgo.co.uk Tel: +44 (0) 1954 233430 Registered in England under Company No. 3315718. VAT No. 688 647 072.
Page 1 of 4
{1}------------------------------------------------
Image /page/1/Picture/0 description: The image shows the word "hidalgo" followed by a series of circles. The first circle is white, while the remaining four circles are black. Above the word "hidalgo" is the text "K113054".
Predicate Devices
The device has been compared to the following predicate:
| Hidalgo | EQ01 | - K061993 |
|---|---|---|
| Additional Predicates: | ||
| GMP Wireless Medicine | LifeSync™ | - K030795 |
| Dymedix Inc | Re-usable Respiratory Effort Belt Sensor | - K040605 |
| Nexan Inc | NX-300 | - K003520 |
| Protocol Systems | Propaq Encore 200 | - K012451 |
| Respironics | Actiheart® | - K052489 |
| Vivometrics | Life Shirt™ Real Time | -K043604 |
Device Description
The Equivital™ Vital Signs Physiological Monitor comprises two components:
i) A chest belt containing skin electrodes and an expansion sensor
ii) A battery powered electronics module which connects directly to the chest belt and which acts to record, digitise and transmit the physiological information wirelessly to a receiving display device.
The device offers continuous monitoring of two views of the user's heart electrical activity (ECG) and respiratory breathing frequency inferred from thoracic cavity movement and uses this data to derive a Heart Rate and a Breathing Effort Rate.
The sensor also provides the following information:
- ECG and Respiration physiological waveforms .
- An indication of the user's activity level derived from a movement detection sensor .
- Body orientation and indications for change in orientation .
- Skin surface temperature .
- Alternate secondary measurement of heart rate based on the detection of the user's R . wave using a separate hardware processing function
- . Indications and alerts if physiology exceeds predefined boundaries
- Alternate secondary skin temperature measurement using infrared thermometer .
The device offers two variants for the wireless interface: a low power radio interface and a general purpose interface using Bluetooth™ technology.
The device offers two battery power options for the user, rechargeable or primary disposable cells.
The wireless data provided by the sensor may be viewed using a standalone PC based viewing application, or integrated into third party monitoring applications.
{2}------------------------------------------------
KII.3054 hidalao……………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………
intended Use Summary
The Equivital™ Vital Signs Physiological Monitor is an ambulatory multiparameter vital signs telemetry device intended for monitoring of adults (16 - 65 years) in hospital care facilities, the home, workplace, and alternate care settings.
The device consists of a chest belt harness and a body worn electronics module (SEM) supported by the chest belt.
The device collects and transmits ECG data and rate, respiration data and rate, skin temperature, body orientation and motion.
The monitor is indicated for use as a general patient monitor, to provide physiological information as part of an occupational welfare monitoring system, and for general research and performance measurement purposes.
Technological Characteristics
The device does not contain tissues of animal origin as referred to in EC commission directive 2003/32/EC.
Substantial equivalence has been demonstrated by technological review and comparison fo the predicate Equivital EQ01 device and verified by the Design Control Process.
In addition substantial equivalence remains to the Equivital EQ01 predicate devices cited in that device's submission.
| Function | Predicate Device | Additional Predicates |
|---|---|---|
| ECG Heart Rate,Breathing RateTemperature andGeneral PhysicalProperties | Hidalgo Equivital EQ01 –K061993 | Protocol SystemsPropaq Encore 200 –K012451Nexan Inc NX-300 –K003520 |
| Chest ExpansionRespiration | Hidalgo Equivital EQ01 –K061993 | Dymedix Re-usableRespiratory Effort Belt –K040605Nexan Inc NX-300 –K003520Vivometrics LifeShirtReal Time –K043604 |
| Activity/MotionDetection | Hidalgo Equivital EQ01 –K061993 | Respironics Actiheart –K052489Vivometrics LifeShirtReal Time – |
Technological Characteristics Compared:
Page 3 of 4
{3}------------------------------------------------
| Function | Predicate Device | Additional Predicates |
|---|---|---|
| K043604 | ||
| Bluetooth telemetryand ECG transmission | Hidalgo Equivital EQ01 -K061993 | GMP WirelessMedicine - LifeSync™K030795 |
| Low Power 40.68MHzPAN | Hidalgo Equivital EQ01 -K061993 | Respironics Actiheart -K052489 |
Performance Measurement Summary
Performance measurement and review to the applicable sections of the following standards has been undertaken and successfully demonstrated as recommended by available guidance from the agency:
- EN60601-1: Medical Electrical Equipment Part 1 General Requirements for Safety. .
- . IEC60601-1-2: 2001 Medical Electrical Equipment Part 1-2: Collateral Standard: Electromagnetic Compatibility.
- ISO 10993-1: Biological Evaluation of Medical Devices: Evaluation and Testing. ●
- ANSI/AAMI EC13: 2002 Cardiac Monitors, heart rate meters, and alarms. The device was . not evaluated against the criteria for defibrillation and pacemaker immunity as it is not indicated for use in either of these cases.
- ASTM E1965 98 (2009) Standard Specification for Infrared Thermometers for internittent . determination of patient temperature.
- . IP67: Environmental Performance Testing
The device software has been developed using a structured software lifecycle which meets the requirements of EN60601-1-4 Programmable Systems, which also applies to ongoing maintenance of the software.
Substantial Equivalence Conclusion
EQ02 has the same intended use and fundamental scientific technology as EQ01. The changes made do not raise any new questions of safety and effectiveness.
In addition the testing undertaken has demonstrated that the Equivital EQ02 device is as safe, as effective and performs as well as the legally marketed predicate Equivital EQ01 device.
To conclude substantial equivalence of the Equivital™ Vital Signs Physiological Monitor EQ02 has been demonstrated to the identified predicate Equivital™ Vital Signs Physiological Monitor EQ01.
Page 4 of 4
{4}------------------------------------------------
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/4/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized caduceus symbol, which is a staff with two snakes coiled around it. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular pattern around the caduceus symbol.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
FEB 1 7 2012
Hidalgo Limited c/o Dr. Ekta Sood Unit F, Buckingway Business Park Anderson Road Swavesey Cambridge Cambridgeshire CB24 4UQ GB
Re: K113054 Trade/Device Name: Equivital Regulation Number: 21 CFR 870.1025 Regulation Name: Monitor, Physiological, Patient (With Arrhythmia Detection or Alarms) Regulatory Class: Class II Product Code: MHX Dated: January 27, 2012 Received: January 30, 2012
Dear Dr. Sood:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
{5}------------------------------------------------
Page 2 - Dr. Ekta Sood
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
R. D. Zaharov, M.P.
fo
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{6}------------------------------------------------
Indications for Use
510(k) Number (if known):_K113054
Device Name: Equivital™ EQ02 Vital Signs Physiological Monitor
Indications For Use:
The Equivital™ Vital Signs Physiological Monitor is an ambulatory multiparameter vital signs telemetry device intended for monitoring of adults (16 - 65years) in hospital in the mital in the mater vital care facilities, the home, workplace for monitoning of addits (11)
facilities, the home, workplace and alternate care settings.
The device consists of a chest belt harness and a body worn electronics module (SEM) supported by the chest belt.
The device collects and transmits ECG data and rate, respiration data and rate, skin
temperature, body orientation and motion temperature, body orientation and motion.
The monitor is indicated for use as a general patient monitor, to provide physiological information as part of an occupational welfare monitor, to provide physiology
research and performance measuroment purpos research and performance measurement purposes.
Federal Law (US) restricts this device to sale by or on the order of a physician
Prescription Use × (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(Please do not write below this line-continue on another page if needed)
Concurrence of CDRH, Office of Device Evaluation (ODE)
ion Slanovascular Devices inn of Car
510(k) Number K113054
§ 870.1025 Arrhythmia detector and alarm (including ST-segment measurement and alarm).
(a)
Identification. The arrhythmia detector and alarm device monitors an electrocardiogram and is designed to produce a visible or audible signal or alarm when atrial or ventricular arrhythmia, such as premature contraction or ventricular fibrillation, occurs.(b)
Classification. Class II (special controls). The guidance document entitled “Class II Special Controls Guidance Document: Arrhythmia Detector and Alarm” will serve as the special control. See § 870.1 for the availability of this guidance document.